Lista de obras - Christopher R. Cogle - Dominio Público Uruguay

A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia

artículo científico publicado en 2019

A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials.

artículo científico publicado en 2013

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients

scientific article published on 01 June 2019

Acute myeloid leukemia in the vascular niche.

artículo científico publicado en 2015

Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro

artículo científico publicado en 2012

Adult human hematopoietic cells provide functional hemangioblast activity

artículo científico publicado en 2003

Aldehyde dehydrogenase activity as a functional marker for lung cancer

artículo científico publicado en 2008

An overview of stem cell research and regulatory issues

artículo científico publicado en 2003

Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies ⬇️

artículo científico publicado el 5 de septiembre de 2011

Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.

artículo científico publicado en 2014

Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry

artículo científico publicado en 2007

Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger.

artículo científico publicado en 2009

Bone marrow transdifferentiation in brain after transplantation: a retrospective study

artículo científico publicado en 2004

Bone marrow-derived stem-cell repopulation contributes minimally to the Type II pneumocyte pool in transplanted human lungs

artículo científico publicado en 2005

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

artículo científico publicado en 2003

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia

artículo científico publicado en 2018

Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care

scientific article published on 17 July 2020

Characteristics of thawed autologous umbilical cord blood

artículo científico publicado en 2012

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study

artículo científico publicado en 2016

Continuous Rural-Urban Coding for Cancer Disparity Studies: Is It Appropriate for Statistical Analysis?

artículo científico publicado en 2019

Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale ⬇️

artículo científico publicado el 1 de diciembre de 2011

Developmental differences in megakaryocyte maturation are determined by the microenvironment

artículo científico publicado en 2005

Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes ⬇️

artículo científico publicado el 17 de agosto de 2011

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

artículo científico publicado en 2005

Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition

artículo científico publicado en 2015

Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Ne

artículo científico publicado en 2012

Finding incident cancer cases through outpatient oncology clinic claims data and integration into a state cancer registry

artículo científico publicado en 2020

Fishing for myelodysplastic syndromes finds uncaptured cases by state cancer registries: Need for more resources

artículo científico publicado en 2014

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia

artículo científico publicado en 2020

Functional integration of acute myeloid leukemia into the vascular niche.

artículo científico publicado en 2014

High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment.

artículo científico publicado en 2013

Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes

scientific article published on 08 May 2020

Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.

artículo científico publicado en 2011

Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design ⬇️

artículo científico publicado el 1 de agosto de 2010

Mapping hematopoiesis in a fully regenerative vertebrate: the axolotl

artículo científico publicado en 2014

Marrow cell therapies for cardiovascular diseases.

artículo científico publicado en 2008

Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.

artículo científico publicado en 2010

Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells

artículo científico publicado en 2009

Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts

artículo científico publicado en 2006

Overcoming Chronic Myeloid Leukemia Stem Cell Resistance to Imatinib by Also Targeting JAK2 ⬇️

artículo científico publicado el 27 de febrero de 2013

PARP1 is required for chromosomal translocations.

artículo científico publicado en 2013

Radiation alone for solid tumors and the questionable development of therapy-related myelodysplastic syndromes

artículo científico publicado en 2014

Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes

artículo científico publicado en 2020

Response to letter regarding article, "a detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b and clonogenic capacity as biomarkers for clinical outcomes".

artículo científico publicado en 2014

Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes

scientific article published on 01 April 2020

Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus

artículo científico publicado en 2012

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study

artículo científico publicado en 2014

The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow

artículo científico publicado en 2011

The Stilbenoid Tyrosine Kinase Inhibitor, G6, Suppresses Jak2-V617F-mediated Human Pathological Cell Growth in Vitro and in Vivo ⬇️

artículo científico publicado el 2 de diciembre de 2010

The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis.

artículo científico publicado en 2012

The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

artículo científico publicado en 2006

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

artículo científico publicado en 2016

Underreporting of Myeloid Malignancies by United States Cancer Registries ⬇️

artículo científico publicado el 11 de enero de 2012

Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells.

artículo científico publicado en 2012

Lista de obras de Christopher R. Cogle

A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia

A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials.

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients

Acute myeloid leukemia in the vascular niche.

Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro

Adult human hematopoietic cells provide functional hemangioblast activity

Aldehyde dehydrogenase activity as a functional marker for lung cancer

An overview of stem cell research and regulatory issues

Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies ⬇️

Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.

Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry

Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger.

Bone marrow transdifferentiation in brain after transplantation: a retrospective study

Bone marrow-derived stem-cell repopulation contributes minimally to the Type II pneumocyte pool in transplanted human lungs

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia

Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care

Characteristics of thawed autologous umbilical cord blood

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study

Continuous Rural-Urban Coding for Cancer Disparity Studies: Is It Appropriate for Statistical Analysis?

Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale ⬇️

Developmental differences in megakaryocyte maturation are determined by the microenvironment

Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes ⬇️

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition

Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Ne

Finding incident cancer cases through outpatient oncology clinic claims data and integration into a state cancer registry

Fishing for myelodysplastic syndromes finds uncaptured cases by state cancer registries: Need for more resources

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia

Functional integration of acute myeloid leukemia into the vascular niche.

High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment.

Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes

Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.

Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design ⬇️

Mapping hematopoiesis in a fully regenerative vertebrate: the axolotl

Marrow cell therapies for cardiovascular diseases.

Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.

Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells

Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts

Overcoming Chronic Myeloid Leukemia Stem Cell Resistance to Imatinib by Also Targeting JAK2 ⬇️

PARP1 is required for chromosomal translocations.

Radiation alone for solid tumors and the questionable development of therapy-related myelodysplastic syndromes

Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes

Response to letter regarding article, "a detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b and clonogenic capacity as biomarkers for clinical outcomes".

Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes

Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study

The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow

The Stilbenoid Tyrosine Kinase Inhibitor, G6, Suppresses Jak2-V617F-mediated Human Pathological Cell Growth in Vitro and in Vivo ⬇️

The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis.

The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

Underreporting of Myeloid Malignancies by United States Cancer Registries ⬇️

Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells.